Zepp Health Corporation

NYSE:ZEPP

Consumer Electronics

Technology
$3.55 -0.58%

-$0.03 today

Market cap
$50.84M
Beta
1.78
P/E (TTM)
-0.1
EPS (TTM)
-$282.07
52W Low $2.36High $61.85

Volume 0.04M

Average 0.13M

ZEPP Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Zepp Health CorporationNYSE: ZEPP

Other Non-Cash Items · Q4 FY2025 · quarter ended Dec 2025

Other non-cash items turns negative

Q4 FY2025 other non-cash items was -CN¥1.29B, compared with CN¥262.22M a year earlier. Trailing-twelve-month other non-cash items was -CN¥1.09B. Over 3 fiscal years it compounded at +291.1% a year.

Context

  • Other non-cash items amounted to 8.0% of revenue in FY2025, up 6.5 pp from a year earlier.
  • Other non-cash items increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other non-cash items holds near -CN¥1.29B or moves back toward the trailing-twelve-month quarterly average of -CN¥271.31M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
-CN¥1.29B-11318.4% QoQ
Last fiscal yearDec 2025
CN¥145.71M+610.3% YoY
LTMDec 2025
-CN¥1.09B-300.7% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-592.2%——
1 year+610.3%——
3-year CAGR+291.1%——
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

CNY · from the cash flow

Latest · FY2025
145.71M CNY
Year-over-year change
+610.3%
4-year CAGR
+5.0%

Other Non-Cash Items vs competitors

How ZEPP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -300.7% is the lowest of 8, against a peer median of +14.3%.
  • Other non-cash items amounts to 58.8% of revenue for ZEPP, versus a peer median of 10.5%.
ZEPP Competitors
Other Non-Cash Items for ZEPP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZEPPZepp Health CorporationLTM Dec 2025CN¥1.09B CNY-300.7%+291.1%58.8%
TTECTTEC Holdings, Inc.LTM Mar 2026$220.52M USD-13.6%+58.8%10.5%
BWBabcock & Wilcox Enterprises, Inc.LTM Mar 2026$55.4M USD+239.2%+72.6%8.3%
STEMStem, Inc.LTM Mar 2026$53.04M USD-107.6%—34.7%
KULRKULR Technology Group, Inc.LTM Mar 2026$28.7M USD+135.5%+165.4%154.6%
TROOTROOPS, Inc.FY2025$13.03M USD+14.3%—76.2%
SVCOSilvaco Group, Inc. Common StockLTM Mar 2026$6.29M USD-85.9%+153.8%9.4%
EXFYExpensify, Inc.LTM Mar 2026$1.74M USD+159.4%-6.2%1.2%
Peer median (excluding ZEPP) —+14.3%+72.6%10.5%

Competitors are the stored peer set for ZEPP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income136.02M(43.35M)(31.09M)(75.81M)(280.18M)
Depreciation & Amortization51.21M8.71M7.69M5.02M31.71M
Deferred Income Tax(18.45M)(9.92M)(2.88M)13.45M15.65M
Stock-Based Compensation07.27M8.79M4.78M17.43M
Change in Working Capital(620.52M)(82.26M)47.88M7.66M(109.97M)
Accounts Receivables300.79M3.13M43.8M404K(80.68M)
Inventory(82.05M)27.92M51.91M5.56M(154.48M)
Accounts Payables(664.51M)(135.34M)(27.82M)14.81M197.86M
Other Working Capital(174.76M)22.03M(20.02M)(13.11M)(72.67M)
Other Non-Cash Items119.98M2.44M12.21M20.51M145.71M
Operating Cash Flow(331.77M)(117.11M)42.6M(24.39M)(179.65M)
Capital Expenditures(45.46M)(1.47M)(1.68M)(1.49M)(5.48M)
Acquisitions (Net)35.99M60K427K00
Purchases of Investments(1.06B)(4.32M)(282K)(7M)0
Sales of Investments24.68M1.8M5.93M5.16M11.67M
Other Investing Activities0(2.57M)3.25M1.66M2.29M
Investing Cash Flow(1.06B)(6.24M)7.73M(1.58M)10.35M
Debt Repayment654.58M16.55M(46.98M)(1.65M)(51.29M)
Common Stock Issued5.39M0000
Common Stock Repurchased(13.58M)(8.16M)(2.52M)(2.28M)(8.66M)
Dividends Paid0(6.31M)000
Other Financing Activities040.28M7.82M4.4M233.61M
Financing Cash Flow646.39M42.37M(41.68M)477K173.66M
Effect of Forex Changes33.47M(14.77M)(9.31M)(4.24M)11.01M
Net Change in Cash(707.46M)(95.76M)(652K)(29.73M)15.37M
Free Cash Flow(377.22M)(118.59M)40.92M(25.88M)(185.14M)

Zepp Health Corporation

NYSE:ZEPP

Intrinsic Alpha fair value

Locked

Current Price

$3.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.